Furlan-Magaril, Mayra https://orcid.org/0000-0002-6771-6631
Ando-Kuri, Masami
Arzate-Mejía, Rodrigo G.
Morf, Jörg
Cairns, Jonathan
Román-Figueroa, Abraham
Tenorio-Hernández, Luis
Poot-Hernández, A. César
Andrews, Simon
Várnai, Csilla
Virk, Boo
Wingett, Steven W.
Fraser, Peter
Funding for this research was provided by:
UNAM Technology Innovation and Research Support Program PAPIIT (IN207319)
Consejo Nacional de Ciencia y Tecnología (15758)
FP7 Ideas: European Research Council (259743)
Biotechnology and Biological Sciences Research Council (BB/J004480/1)
European Research Council (340152)
Article History
Received: 20 August 2020
Accepted: 5 May 2021
First Online: 8 June 2021
Declarations
:
: C57BL/6 male mice were maintained in the Babraham Institute Animal Facility and all applied procedures were approved by the Animal Welfare and Ethical Review Body (AWERB) considering the animal welfare practices according to the Home Office in the UK.
: Not applicable.
: J.C. is currently an employee of AstraZeneca and may or may not own stock options. The rest of the authors declare no competing interests.